Dexcom's glucose monitor now provides users with an AI-generated summary of the effects of sleep, meals, and other factors on blood sugar levels.

• On Tuesday, Dexcom unveiled its first AI-powered feature for the Stelo biosensor, which generates a customized weekly report on glucose levels for users.
• The company has been developing a generative AI platform utilizing Google Cloud technology.
• The report provides information on how Stelo users' diet, rest, and exercise affect their blood sugar levels, along with helpful advice and learning resources.

The company announced an AI feature for its Stelo continuous glucose monitor on Tuesday. This feature provides users with a personalized view of how meals, sleep, and activity affect their glucose levels. It is the first iteration of a new generative AI platform that the company has been developing with.

An over-the-counter CGM that measures real-time blood sugar levels through the skin, Stelo, was launched in August and is accessible to any adult who doesn't use insulin.

Dexcom is striving to personalize and engage consumers with Stelo in order to enter a new market, as reflected in the report.

"According to Jake Leach, chief operating officer at Dexcom, the most common feedback received is that users want to see more. They are investing in the product and wearing it, and they want to maximize the use of the data generated."

Dexcom is leveraging Google's Gemini models and Vertex AI platform to create its new AI solution. Vertex AI enables developers to develop applications that integrate diverse data types, which is often challenging in healthcare.

Dexcom is considering how its generative AI platform can be applied to its other continuous glucose monitoring (CGM) products, but the company is taking extra precautions because patients rely on these devices to prevent medical emergencies.

He said that it truly felt like Stelo was the ideal location for his first time doing it.

The AI-generated report, which is personalized, is expected to be more valuable to users than the existing insights report available in the Stelo app, which followed a standard template format each week, according to Leach.

If a user is not moving enough after meals, the report would provide relevant tips and educational materials to help.

Though Dexcom has been using an AI framework from the U.S. Food and Drug Administration to help guide the development of Stelo's AI reports, Leach stated that the reports do not provide medical advice. The FDA approved Stelo in March.

Dexcom aims to utilize its generative AI platform to provide real-time feedback to users instead of weekly reports, while also investigating its potential as a predictive indicator for impending issues, similar to a car's check engine light.

Chris Sakalosky, vice president of strategic industries for Google Cloud, advised CNBC in an interview that it provides a sense of what could be happening and recommendations on where to seek further advice.

Dexcom's updated weekly report began rolling out to Stelo users this week.